Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Genentech VP-Business Development Joseph McCracken: An Interview With "The Pink Sheet" DAILY (Part 2 of 2)

Oct 20 2006

• By The Pink Sheet Daily

Related Content

Rituxan Adds Third NHL Indication In 2006

Oct 02 2006

Genentech Adds Patient Assistance Program Along With Avastin Lung Cancer Indication

Oct 12 2006

Pfizer/OSI To Curtail Macugen Research In Response To Genentech Competition

Aug 08 2006

Novartis Head Of Pharma Development James Shannon: An Interview With “The Pink Sheet” DAILY (Part 1 of 2)

Jul 21 2006

Genentech Will Collaborate With CGI To Develop Oncology, Autoimmune Target

Oct 04 2006

Genentech Gains PARP Inhibitor Through Inotek Deal

Jul 25 2006

Merck VP &amp; Chief Licensing Officer Barbara Yanni: An Interview With “The Pink Sheet” DAILY

Jun 19 2006

AstraZeneca’s New Head Of Strategic Planning &amp; Business Development John Goddard: An Interview With “The Pink Sheet” DAILY (Part 1 of 2)

Sep 22 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window